The DOI matches its Crossref record; 240 of the 240 references it cites were found in a registry or an index.
The Response-to-Retention Hypothesis of Early Atherogenesis
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The retention of lipoproteins in the arterial extracellular matrix is a critical step in atherogenesis in which lipoproteins with higher affinity for arterial proteoglycans are more atherogenic (55, 56).”
From Role of the N- and C-Terminal Domains in Binding of Apolipoprotein E Isoforms to Heparan Sulfate and Dermatan Sulfate: A Surface Plasmon Resonance Study (2008) · cites this paper as [55]
In the citing paper
“The ECM has a central role in initiation of atherosclerosis, primarily through the interaction between the negatively charged side chains of proteoglycans (particularly chondroitin sulphate of biglycan and versican and heparin sulphate of perlecan 110 ) with positively charged apolipoproteins (especially apolipoprotein B) , which leads to the retention of plasma-derived lipoproteins 101,111 - as”
From Vascular smooth muscle cells in atherosclerosis (2019) · cites this paper as [113]
In the citing paper
“the interaction of apoB-containing lipoproteins (the non-HDL lipoproteins) with intimal extracellular proteoglycans (referred to as retention)1,43,44 inhibits the movement of the lipoproteins, thereby resulting in much higher subendothelial concentrations of these lipoproteins in the intima than in any other tissue45.”
From Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities (2019) · cites this paper as [1]
In the citing paper
“Atherosclerosis is a disease characterized by low-grade, chronic inflammation of the arterial wall and is triggered by the subendothelial retention of plasma-derived, apolipoprotein B (apoB)-containing lipoproteins in the affected inner layer of the arterial wall, the intima1–3.”
From Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities (2019) · cites this paper as [1]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–240 of 240
Familial hypobetalipoproteinemia. Absence of atherosclerosis in a postmortem study
Kahn, J. A. (1978) · JAMA · doi:10.1001/jama.240.1.47 · Cited by 27
Lipoprotein (a) in the arterial wall
Beisiegel, U. (1991) · Current Opinion in Lipidology · doi:10.1097/00041433-199110000-00008 · Cited by 25
Fry, D. L., Haupt, M. W., & Pap, J. M. (1992) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.12.11.1313 · Cited by 25
Chisolm, G. M. (1993) · PubMed · Cited by 25
Progress in coronary artery disease risk-factor research: what remains to be done?
Crouse, J. R. (1984) · Clinical Chemistry · doi:10.1093/clinchem/30.7.1125 · Cited by 25
Proteoglycans, Lipoproteins, and Atherosclerosis
Srinivasan, S. R., Radhakrishnamurthy, B., Vijayagopal, P., et al. (1990) · Advances in experimental medicine and biology · doi:10.1007/978-1-4684-5904-3_45 · Cited by 24
Keesler, G. A., Li, Y., Skiba, P. J., et al. (1994) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.14.8.1337 · Cited by 24
Interaction of lipoprotein(a) with fibronectin and its potential role in atherogenesis
Ehnholm, C., Jauhiainen, M., & Metso, J. (1990) · European Heart Journal · doi:10.1093/eurheartj/11.suppl_e.190 · Cited by 23
Merrilees, M. J., & Scott, L. (1990) · Atherosclerosis · doi:10.1016/0021-9150(90)90073-r · Cited by 22
LDL accumulation in the grossly normal human iliac bifurcation and common iliac arteries
Spring, P. M., & Hoff, H. F. (1989) · Experimental and Molecular Pathology · doi:10.1016/0014-4800(89)90018-x · Cited by 22
Yashiro, A., O'Neil, J. C., & Hoff, H. F. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53454-2 · Cited by 21
Schwenke, D. C., & Clair, R. W. S. (1992) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.12.4.446 · Cited by 21
Tertov, V. V., Orekhov, A. N., Ryong, L. H., et al. (1988) · Tissue and Cell · doi:10.1016/0040-8166(88)90026-2 · Cited by 21
Familial Hypobetalipoproteinemia
Kahn, J. A. (1978) · JAMA · doi:10.1001/jama.1978.03290010051023 · Cited by 21
Antioxidants and atherosclerosis progression: unresolved questions
Elinder, L. S., & Walldius, G. (1994) · Current Opinion in Lipidology · doi:10.1097/00041433-199408000-00004 · Cited by 20
[Antioxidant effect of high-density lipoproteins in the peroxidation of low-density lipoproteins].
Klimov, A. N., Kozhemiakin, L. A., Vm, P., et al. (1987) · PubMed · Cited by 20
Time course of 125I-labeled LDL accumulation in the healing, balloon-deendothelialized rabbit aorta.
Chang, M. Y., Lees, A. M., & Lees, R. S. (1992) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.12.9.1088 · Cited by 20
Inhibition by serum components of oxidation and collagen-binding of low-density lipoprotein
Kalant, N., & McCormick, S. U. (1992) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(92)90310-r · Cited by 18
Antioxidant effect of high-density lipoproteins in peroxidation of low-density lipoproteins
Klimov, A. N., Kozhemyakin, L. A., Pleskov, V. M., et al. (1987) · Bulletin of Experimental Biology and Medicine · doi:10.1007/bf00841817 · Cited by 18
Pathobiochemical Changes of the Arterial Wall at the Inception of Atherosclerosis
Simionescu, N., Sima, A. V., Dobrian, A. D., Tı̂rziu, D., & Simionescu, M. (1993) · Current topics in pathology · doi:10.1007/978-3-642-76849-1_1 · Cited by 17
Regulation of macrophage lipoprotein lipase secretion by the scavenger receptor
Murata, Y., Behr, S. R., & Kraemer, F. B. (1988) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/0167-4889(88)90097-3 · Cited by 17
Rosenfeld, M. E., Carew, T. E., von Hodenberg, E., Pittman, R. C., Ross, R., & Steinberg, D. H. (1992) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.12.8.985 · Cited by 17
Distribution of low density lipoprotein in the branch and non-branch regions of the aorta
Thubrikar, M. J., Keller, A. C., Holloway, P. W., & Nolan, S. P. (1992) · Atherosclerosis · doi:10.1016/0021-9150(92)90045-i · Cited by 17
Interaction between fibronectin, proteoglycans and lipoproteins
Labat‐Robert, J., Gruber, É., & Bihari-Varga, M. (1990) · International Journal of Biological Macromolecules · doi:10.1016/0141-8130(90)90081-k · Cited by 17
The role of the endothelium in atherogenesis
DiCorleto, P. E., & Soyombo, A. A. (1993) · Current Opinion in Lipidology · doi:10.1097/00041433-199310000-00004 · Cited by 17
Lipoprotein (a) regulates plasmin generation and inihibition
Edelberg, J. M., & Pizzo, S. V. (1994) · Chemistry and Physics of Lipids · doi:10.1016/0009-3084(94)90158-9 · Cited by 17
Effects of lipoprotein(a) on lysis of whole blood thrombi from healthy volunteers
Terres, W., Krewitt, M., & Hamm, C. W. (1993) · Thrombosis Research · doi:10.1016/0049-3848(93)90236-h · Cited by 15
Camejo, G., Hurt, E., Thubrikar, M., et al. (1991) · PubMed · Cited by 15
Mori, N., Yamada, N., Ishibashi, S., Kawakami, M., Takahashi, K., Shimano, H., Fujisawa, M., Takaku, F., & Murase, T. (1987) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(87)90143-3 · Cited by 12
LFry, D., WHaupt, M., & MPap, J. (1992) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · Cited by 12
Binding of fibronectin to human lipoproteins
Cseh, K., Karádi, I., Rischák, K., et al. (1989) · Clinica Chimica Acta · doi:10.1016/0009-8981(89)90151-4 · Cited by 11
Sachinidis, A., Locher, R., Steiner, A., et al. (1989) · Journal of Hypertension · doi:10.1097/00004872-198900076-00054 · Cited by 11
Cholesterol and atherosclerosis: “The new is the old rediscovered”
Hoeg, J. M., & Klimov, A. N. (1993) · The American Journal of Cardiology · doi:10.1016/0002-9149(93)90863-8 · Cited by 10
Kempen, H. J. M., Buytenhek, M., Gruber, É., et al. (1989) · Atherosclerosis · doi:10.1016/0021-9150(89)90217-7 · Cited by 10
[Pathogenesis of atherosclerosis: an update on the three main theories].
Capron, L. (1989) · PubMed · Cited by 10
Ylä‐Herttuala, S., Pesonen, E. J., Kaprio, E., Rapola, J., Soveri, T., Viikari, J. S. A., Savilahti, E., Oksanen, H. E., & Nikkari, T. (1988) · Atherosclerosis · doi:10.1016/0021-9150(88)90078-0 · Cited by 9
Wiklund, O., Camejo, G., Mattsson, L., et al. (1990) · Arteriosclerosis An Official Journal of the American Heart Association Inc · doi:10.1161/01.atv.10.5.695 · Cited by 9
Regulation of macrophage lipoprotein lipase secretion by the scavenger receptor
Murata, Y., Behr, S. R., & Kraemer, F. B. (1988) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/s0005-2728(88)80087-2 · Cited by 9
Görög, P., & Born, G. V. R. (1993) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.13.5.637 · Cited by 4
The 16th annual meeting of the European Lipoprotein Club.
Stalenhoef, A. F. H., Armstrong, V., Humphries, S. E., et al. (1994) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.14.5.831 · Cited by 2
Research works printed but not linked: 64
- 1949, Arch Pathol, 48, 342
- 1991, Adv Exp Med Biol, 285, 373
- 1991, Atheroscler Rev, 23, 91
- 10.1161/atv91.14.5.8172861 · DOI
- 1977, Am J Pathol, 86, 675
- 1992, Am J Pathol, 140, 907
- 10.1161/atv91.12.9.1525124 · DOI
- 1992, Arch Pathol Lab Med, 116, 1301
- 10.1161/atv91.13.8.8343497 · DOI
- 1992, Arch Pathol Lab Med, 116, 1292
- 1957, Arch Pathol, 64, 303
- 10.1161/atv91.12.12.1450173 · DOI
- 10.1161/atv91.13.8.8343494 · DOI
- 10.1161/atv91.14.2.8305425 · DOI
- 1913, Zentralbl Allg Pathol, 24, 1
- 1989, Ann Cardiol Angeiol (Paris), 38, 631
- 10.1161/atv91.13.9.8364021 · DOI
- 1984, Am J Pathol, 114, 112
- 10.1161/atv91.12.4.1558836 · DOI
- 10.1161/atv91.12.11.1420090 · DOI
- 10.1161/atv91.12.11.1420091 · DOI
- 1994, Am J Pathol, 144, 952
- 10.1161/atv91.13.2.7678986 · DOI
- 10.1161/atv91.11.6.1931881 · DOI
- 10.1161/atv91.14.3.8123647 · DOI
- 1993, Lab Invest, 68, 369
- 1991, Am J Pathol, 139, 101
- 10.1161/res.72.2.8418981 · DOI
- 10.1161/res.74.1.8261591 · DOI
- 10.1161/atv91.12.11.1420084 · DOI
- 10.1161/atv91.14.1.8274468 · DOI
- 1983, Am J Pathol, 113, 156
- 10.1161/atv91.14.1.8274466 · DOI
- 1988, Am J Pathol, 131, 73
- 1986, Am J Pathol, 123, 109
- 10.1161/circ.85.6.1591855 · DOI
- 10.1161/atv91.12.5.1576119 · DOI
- 10.1161/atv91.13.11.7692957 · DOI
- 10.1161/atv91.14.1.7506053 · DOI
- 1994, Am J Med, 97, 3A
- Lund G Beisiegel U Seeber N Nikutta P Hamm CW. Effect of probucol on progression/regression of coronary artery disease. In: Abstracts Submitted to the Council on Arteriosclerosis for the 66th Scientific Sessions of the American Heart Association . Dallas Tex: American Heart Association Inc; 1993:124.
- 10.1161/atv91.14.5.8172860 · DOI
- 10.1161/atv91.11.5.1911712 · DOI
- 10.1161/atv91.12.5.1576122 · DOI
- 10.1161/atv91.13.12.8241102 · DOI
- 10.1161/atv91.14.7.8018672 · DOI
- 10.1161/circ.60.3.222498 · DOI
- 10.1161/atv91.13.2.8427855 · DOI
- 1986, Lab Invest, 54, 402
- 1994, Am J Pathol, 144, 538
- 10.1161/atv91.12.2.1543697 · DOI
- 10.1161/atv91.12.8.1637798 · DOI
- 1993, Am J Pathol, 142, 1787
- 10.1161/atv91.11.6.1931877 · DOI
- 10.1161/atv91.13.9.8364022 · DOI
- 10.1161/atv91.14.8.8049196 · DOI
- 1990, Eur J Cell Biol, 52, 98
- 1992, Eur J Cell Biol, 59, 314
- 1994, Am J Pathol, 144, 1348
- 10.1161/circ.82.2.2372896 · DOI
- 10.1161/atv91.14.3.8123657 · DOI
- 1993, Am J Pathol, 143, 1551
- 10.1161/atv91.14.9.8068605 · DOI
- 10.1161/atv91.13.5.8485115 · DOI
Cited by
Sorted by citations
Macrophages in the Pathogenesis of Atherosclerosis
Moore, K. J., & Tabas, I. (2011) · Cell · doi:10.1016/j.cell.2011.04.005 · Cited by 2,669
Self-citationBorén, J., Chapman, M. J., Krauss, R. M., Packard, C. J., Bentzon, J. F., Binder, C. J., Daemen, M. J., Demer, L. L., Hegele, R. A., Nicholls, S. J., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz962 · Cited by 1,601
Tabas, I., Williams, K. J., & Borén, J. (2007) · Circulation · doi:10.1161/circulationaha.106.676890 · Cited by 1,399
Self-citationInflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities
Bäck, M., Yurdagul, A., Tabas, I., Öörni, K., & Kovanen, P. T. (2019) · Nature Reviews Cardiology · doi:10.1038/s41569-019-0169-2 · Cited by 1,341
Self-citationChapman, M. J., Ginsberg, H. N., Amarenco, P., Andreotti, F., Borén, J., Catapano, A. L., Descamps, O. S., Fisher, E., Kovanen, P. T., Kuivenhoven, J. A., et al. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr112 · Cited by 1,227
Metadata
- Authors
- Williams, K. J., & Tabas, I.
- Affiliations
- Thomas Jefferson University (US)
- Venue
- Arteriosclerosis, Thrombosis, and Vascular Biology
- Published
- 1995-05
- Volume
- 15
- Issue
- 5
- Pages
- 551-561
- ISSN
- 1079-5642 (ISSN-L)
- 1524-4636
- PMC
- PMC2924812
- OpenAlex
- W1968171440
- Cited by
- 1,413
- References
- 240
- Citations by year
- 2026: 27 · 2025: 34 · 2024: 37 · 2023: 40 · 2022: 42 · 2021: 39 · 2020: 55 · 2019: 47 · 2018: 42 · 2017: 41 · 2016: 59 · 2015: 73 · 2014: 60 · 2013: 56 · 2012: 60
- FWCI
- 12.35
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Arteriosclerosis Thrombosis and Vascular Biology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- American Heart Association
- National Institutes of Health (5p50hl021006-17, 5r01hl039703-08)
- Genentech
- National Heart, Lung, and Blood Institute (HL 38956, HL-39703, HL 21006, R01HL038956)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Keywords
- atherosclerosis initiation, plaque retention, endothelial dysfunction
- MeSH terms
- Animals, Arteries, Arteriosclerosis, Humans, Lipoproteins, LDL, Models, Biological, Proteoglycans
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
